XERS - Xeris Pharmaceuticals EPS beats by $0.19 beats on revenue November, 09 2020 07:25 AM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (XERS): Q3 GAAP EPS of -$0.35 beats by $0.19.Revenue of $9.4M beats by $4.92M.Shares +4.6% PM.Press Release For further details see: Xeris Pharmaceuticals EPS beats by $0.19, beats on revenue